KIT and telomere syndrome: Along with the studies mentioned above, our data shows the limited utility of c-Kit immunostaining as a prognostic marker in certain subtypes of STS, emphasizing the importance of comprehensive diagnostic approaches tailored to the specific histological characteristics of each tumor subtype.